Benefits of HLA Typing by NGS for Organ Transplantation

03/07/2018

Mette Christiansen (Aarhus University Hospital) was focusing on the benefits of HLA typing by NGS for organ transplantation during her User Group Meeting talk at the EFI 2018 conference. The presentation includes slides of the use of high-resolution (vs. low-resolution) typings in solid organ transplantation. Download the full presentation here…

Omixon Educative Series: HLA – Basic Immunological Roles

16/03/2018

Learn more about the role of the human leukocyte antigen (HLA) system in and beyond transplantation! Please find the first part of our HLA Educative Series that targets a wide range of knowledge levels. We start with their basic immunology that will be followed by their roles in transplantation, and...

A Letter from Omixon CEO, Dr. Peter Meintjes

30/01/2018

Dear Customers and Friends of Omixon, 2017 was one heck of a year – a year filled with growth and change; the year the Orville Omixon took flight to unchartered territories (and beyond?). Back in January 2017 we moved our company offices for the second time in our history, as...

How Immunotherapy of Cancer May Create Novel Clinical Utilities for HLA Typing

15/12/2017

Written by Dr. Attila Bérces (Founder and Chairman, Omixon) The article was originally published in ASHI Quarterly Q3 2017 While the role of HLA has been demonstrated in over hundred diseases, its clinical utility and impact outside transplantation has been limited. Transplantation still dominates the demand for HLA genotyping....

Automated NGS-based HLA Typing for Solid Organs at the 43rd ASHI Annual Meeting 2017

11/09/2017

Omixon announce that Holotype HLA and other Omixon products will be featured among eight posters produced by customers or collaborators at the annual meeting of the American Society for Histocompatibility and Immunogenetics (ASHI) in San Francisco, CA. Additionally, Omixon’s Lunchtime Symposium on Thursday will focus on NGS for solid organ...